Materialise NV (06MA)
XSTU 
Summary
06MA Chart
Are Investors Undervaluing Materialise (MTLS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Materialise Q1 Earnings Call Highlights
Materialise NASDAQ: MTLS reported first-quarter 2026 revenue of EUR 66.3 million, which Chief Financial Officer Koen Berges said was stable year-over-year despite “significant foreign exchange headwinds,” primarily tied to a weaker U.S. dollar. Gross profit rose to EUR 37.9 million and gross margin expanded to 57.2%, helping drive improved profitability and positive free cash flow during the period.
Materialise NV (MTLS) Q1 2026 Earnings Call Transcript
Materialise NV (MTLS) Q1 2026 Earnings Call Transcript
Materialise NV (06MA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Materialise NV ever had a stock split?
Materialise NV Profile
| Software Industry | Information Technology Sector | Brigitte de Vet-Veithen CEO | XSTU Exchange | US57667T1007 ISIN |
| BE Country | 488 Employees | - Last Dividend | - Last Split | 25 Jun 2014 IPO Date |
Overview
Materialise NV stands as a pivotal provider in the realms of additive manufacturing and medical software, coupled with 3D printing services, which spans across the Americas, Europe and Africa, and the Asia-Pacific. With its operational foundation laid down in 1990 and headquartered in Leuven, Belgium, Materialise NV has compartmentalized its expertise into three primary segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The company has fostered collaborative agreements with eminent entities like Zimmer Biomet Holdings, Inc., Encore Medical, L.P., DePuy Synthes Companies of Johnson & Johnson, and several others, demonstrating its industry significance and widespread trust. This extensive collaboration network underscores Materialise NV's influential role in advancing 3D printing applications within both industrial and medical frameworks.
Products and Services
- Materialise Software
- Materialise Medical
- Materialise Manufacturing
Facilitates and enhances 3D printing operations through a comprehensive suite of software programs and platforms. This segment bridges various 3D printers with numerous software applications and capturing technologies, including CAD/CAM packages and 3D scanners. Its target clientele encompasses 3D printing machine manufacturers, production companies, and contract manufacturers across industries such as automotive, aerospace, consumer goods, and hearing aids, in addition to 3D printing service bureaus. Distribution is achieved via a direct sales force, a dedicated website, and through third-party resellers.
Focuses on delivering medical software that facilitates the analysis, planning, and engineering based on medical imaging, as well as the patient-specific design and printing of surgical devices and implants. This segment's offerings are primarily directed at medical device companies, hospitals, universities, research institutes, and industrial entities. Distribution is steered through direct sales efforts, the company's website, and Picture Archiving Communication Systems (PACS), underscoring Materialise's pivotal role in innovating medical procedures and patient care.
Provides 3D printing services alongside design and engineering services, catering to the rapid prototyping and additive manufacturing needs of production parts for industrial and commercial clients. This segment encapsulates Materialise NV's direct contribution to the manufacturing industry, showcasing its capabilities in turning conceptual designs into tangible, high-quality parts and products through state-of-the-art 3D printing technologies.
